Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Basik

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
JAMA Surgery|May 7, 2025
Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical TrialMark Basik, Reena S Cecchini, Jennifer F De Los Santos, et al.
Oncogene|February 3, 2022
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotinMarco Biondini, Alex Kiepas, Leeanna El-Houjeiri, et al.
Cancer Research|January 20, 2019
MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma <i>In Situ</i>Qianyu Guo, Vivian Z Li, Jessica N Nichol, et al.
Cancer Research|April 15, 2024
Correction: MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In SituQianyu Guo, Vivian Z Li, Jessica N Nichol, et al.
Nature Communications|June 4, 2021
STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancerStephanie P Totten, Young Kyuen Im, Eduardo Cepeda Cañedo, et al.
European Journal of Human Genetics : EJHG|January 29, 2026
Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortiumKirsten M Farncombe, Julia A Sobotka, Melyssa Aronson, et al.
Nature Communications|July 3, 2019
An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesisHarvey W Smith, Alison Hirukawa, Virginie Sanguin-Gendreau, et al.
Cancer Research|May 12, 2021
The MNK1/2-eIF4E Axis Supports Immune Suppression and Metastasis in Postpartum Breast CancerQianyu Guo, Margarita Bartish, Christophe Gonçalves, et al.
Molecular Cancer Research : MCR|September 21, 2019
A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular VulnerabilityIsabelle Sirois, Adriana Aguilar-Mahecha, Josiane Lafleur, et al.
Cancer Discovery|June 9, 2025
Federated Deep Learning Enables Cancer Subtyping by ProteomicsZhaoxiang Cai, Emma L Boys, Zainab Noor, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
JAMA Surgery|May 7, 2025
Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical TrialMark Basik, Reena S Cecchini, Jennifer F De Los Santos, et al.
Oncogene|February 3, 2022
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotinMarco Biondini, Alex Kiepas, Leeanna El-Houjeiri, et al.
Cancer Research|January 20, 2019
MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma <i>In Situ</i>Qianyu Guo, Vivian Z Li, Jessica N Nichol, et al.
Cancer Research|April 15, 2024
Correction: MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In SituQianyu Guo, Vivian Z Li, Jessica N Nichol, et al.
Nature Communications|June 4, 2021
STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancerStephanie P Totten, Young Kyuen Im, Eduardo Cepeda Cañedo, et al.
European Journal of Human Genetics : EJHG|January 29, 2026
Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortiumKirsten M Farncombe, Julia A Sobotka, Melyssa Aronson, et al.
Nature Communications|July 3, 2019
An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesisHarvey W Smith, Alison Hirukawa, Virginie Sanguin-Gendreau, et al.
Cancer Research|May 12, 2021
The MNK1/2-eIF4E Axis Supports Immune Suppression and Metastasis in Postpartum Breast CancerQianyu Guo, Margarita Bartish, Christophe Gonçalves, et al.
Molecular Cancer Research : MCR|September 21, 2019
A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular VulnerabilityIsabelle Sirois, Adriana Aguilar-Mahecha, Josiane Lafleur, et al.
Cancer Discovery|June 9, 2025
Federated Deep Learning Enables Cancer Subtyping by ProteomicsZhaoxiang Cai, Emma L Boys, Zainab Noor, et al.
Pageof 13